Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomised, Open-label, 3-way Crossover study to evaluate the 2 new Overencapsulated Tablet formulations (Formulation B and C) relative to an overencapsulated form of the early tablet (Formulation A) in Healthy male volunteers

Trial Profile

Randomised, Open-label, 3-way Crossover study to evaluate the 2 new Overencapsulated Tablet formulations (Formulation B and C) relative to an overencapsulated form of the early tablet (Formulation A) in Healthy male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2018

At a glance

  • Drugs Mavatrep (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Oct 2018 Results published in the Clinical Pharmacology in Drug Development
    • 01 Oct 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top